891.59998 EUR
7.6
0.85%
Last update Dec 16, 5:16 PM CET
Main market
Day range
888.099976
914.5
Previous close
899.20001
Open
910.79999
Access this stock data via API
Subscribe
Eli Lilly and Company
891.60
7.60
0.85%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 15.0B 13.3B 10.8B 11.5B
Cost of revenue 2.6B 2.1B 1.9B 2.0B
Gross profit 12.4B 11.2B 9.0B 9.5B
Operating expense
Research & development 3.0B 2.8B 2.3B 2.6B
Selling general and admin 2.2B 2.3B 2.0B 2.0B
Other operating expenses
Operating income 7.2B 6.1B 4.6B 4.9B
Non operating interest income
Income 55.4M 34.1M 41.2M 37.8M
Expense 153.1M 212.2M 207.7M 191.5M
Other income expense -982.7M -120.0M -1.5B -493.2M
Pretax income 6.2B 5.8B 2.9B 4.3B
Tax provision 1.4B 951.0M 593.8M 536.0M
Net income 4.8B 4.8B 2.4B 3.8B
Basic EPS 6.3 3.1 4.9
Diluted EPS 6.3 3.1 4.9
Basic average shares 765.2M 765.1M 764.9M
Diluted average shares 766.9M 767.5M 769.7M
EBITDA 7.5B 6.4B 5.0B 5.4B
Net income from continuing op. 4.8B 4.8B 2.4B 3.8B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 59 minutes

14:30
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).